Edition:
United Kingdom

Vericel Corp (VCEL.OQ)

VCEL.OQ on NASDAQ Stock Exchange Capital Market

17.40USD
7:20pm BST
Change (% chg)

$0.45 (+2.65%)
Prev Close
$16.95
Open
$17.13
Day's High
$17.40
Day's Low
$16.94
Volume
28,519
Avg. Vol
156,860
52-wk High
$21.00
52-wk Low
$10.51

Latest Key Developments (Source: Significant Developments)

Vericel Has Entered Into Exclusive License And Supply Agreements With Mediwound To Commercialize Nexobrid® In North America
Tuesday, 7 May 2019 

May 7 (Reuters) - Vericel Corp ::HAS ENTERED INTO EXCLUSIVE LICENSE AND SUPPLY AGREEMENTS WITH MEDIWOUND TO COMMERCIALIZE NEXOBRID® IN NORTH AMERICA.PIVOTAL U.S. PHASE 3 CLINICAL STUDY MET PRIMARY AND ALL SECONDARY ENDPOINTS.VERICEL -UNDER TERMS, VERICEL WILL MAKE UPFRONT PAYMENT TO MEDIWOUND OF $17.5 MILLION, WITH AN ADDITIONAL $7.5 MILLION PAYMENT CONTINGENT UPON U.S. APPROVAL.VERICEL - UNDER THE TERMS OF THE LICENSE AGREEMENT, VERICEL WILL PAY MEDIWOUND UP TO $125 MILLION CONTINGENT UPON MEETING CERTAIN ANNUAL SALES MILESTONES.VERICEL-ENTERED AGREEMENT WITH MEDIWOUND, WHERE MEDIWOUND WILL MANUFACTURE NEXOBRID FOR VERICEL FOR A SUPPLY PRICE OF COST PLUS FIXED MARGIN PERCENTAGE.  Full Article

Vericel Q4 Earnings Per Share $0.11
Tuesday, 26 Feb 2019 

Feb 26 (Reuters) - Vericel Corp ::VERICEL REPORTS FOURTH QUARTER AND FULL-YEAR 2018 FINANCIAL RESULTS AND PROVIDES FULL-YEAR 2019 FINANCIAL GUIDANCE.Q4 EARNINGS PER SHARE $0.11.Q4 EARNINGS PER SHARE ESTIMATE $0.04 -- REFINITIV IBES DATA.QTRLY GROSS MARGINS OF 72% COMPARED TO GROSS MARGINS OF 64% IN Q4 OF 2017.EXPECTS TOTAL NET PRODUCT REVENUES FOR 2019 TO BE IN RANGE OF $108 MILLION TO $112 MILLION..EXPECTS MARGINS TO CONTINUE TO INCREASE IN 2019.TOTAL NET PRODUCT REVENUES FOR QUARTER ENDED DECEMBER 31, 2018 INCREASED 41% TO $31.3 MILLION COMPARED TO $22.2 MILLION IN Q4 OF 2017.Q4 REVENUE VIEW $28.7 MILLION -- REFINITIV IBES DATA.FY2019 REVENUE VIEW $109.9 MILLION -- REFINITIV IBES DATA.  Full Article

James Flynn Reports 6.15 Pct Passive Stake In Vericel Corp As Of October 10
Monday, 22 Oct 2018 

Oct 22 (Reuters) - Vericel Corp ::JAMES FLYNN REPORTS 6.15 PERCENT PASSIVE STAKE IN VERICEL CORP AS OF OCTOBER 10 - SEC FILING.  Full Article

Vericel Corp Files For Mixed Shelf Of Up To $200 Million
Thursday, 16 Aug 2018 

Aug 16 (Reuters) - Vericel Corp ::VERICEL CORP FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING.  Full Article

Vericel Reports Second Quarter Revenue Of $19 Million
Monday, 6 Aug 2018 

Aug 6 (Reuters) - Vericel Corp ::VERICEL REPORTS RECORD SECOND QUARTER REVENUES OF $19.0 MILLION AND RAISES FULL YEAR 2018 REVENUE GUIDANCE.Q2 LOSS PER SHARE $0.12.Q2 REVENUE $19 MILLION VERSUS I/B/E/S VIEW $18.6 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE $80 MILLION TO $83 MILLION.FY2018 REVENUE VIEW $78.1 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Vericel Corporation Prices $65 Mln Public Offering Of Common Stock
Friday, 1 Jun 2018 

May 31 (Reuters) - Vericel Corp ::ORATION PRICES $65 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 5.00 MILLION COMMON SHARES PRICED AT $13.00PER SHARE.  Full Article

Vericel Initiates Collaboration with Innovative Cellular Therapeutics
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Vericel Corp ::VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​.VERICEL - ‍UNDER DEAL,ICT WILL DEVELOP,DISTRIBUTE MACI EPICE,IXMYELOCEL-T,CARTICEL IN GREATER CHINA,SOUTH KOREA, SINGAPORE, OTHER COUNTRIES IN REGION​.  Full Article

Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap Financial
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Vericel Corp ::VERICEL ENTERS INTO EXPANDED $25 MILLION DEBT FACILITIES WITH SILICON VALLEY BANK AND MIDCAP FINANCIAL TO SUPPORT ACCELERATING MACI UPTAKE AND INCREASED EPICEL USAGE.VERICEL-ENTERED INTO EXPANDED $15 MILLION TERM LOAN, RETAINED EXISTING $10 MILLION REVOLVING LINE OF CREDIT WITH SILICON VALLEY BANK,MIDCAP FINANCIAL SERVICES​.  Full Article

Vericel reports Q3 loss per share $0.16
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Vericel Corp :Vericel reports third-quarter 2017 financial results.Q3 loss per share $0.16.Q3 revenue $14.3 million versus I/B/E/S view $13.9 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.Vericel Corp - ‍As of September 30, 2017, company had $15.5 million in cash compared to $23.0 million in cash at December 31, 2016​.  Full Article